- Home
- LE vs LXRX Comparison
LE vs LXRX Comparison
Compare LE & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LE | LXRX |
|---|---|---|
| Founded | 1963 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 503.8M | 541.5M |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | LE | LXRX |
|---|---|---|
| Price | $15.39 | $1.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $20.00 | $3.23 |
| AVG Volume (30 Days) | 198.0K | ★ 1.4M |
| Earning Date | 12-09-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.38 | N/A |
| Revenue | ★ $1,314,437,000.00 | $70,864,000.00 |
| Revenue This Year | $2.21 | $56.61 |
| Revenue Next Year | $2.44 | N/A |
| P/E Ratio | $40.69 | ★ N/A |
| Revenue Growth | N/A | ★ 1255.21 |
| 52 Week Low | $7.65 | $0.28 |
| 52 Week High | $17.12 | $1.66 |
Technical Indicators
Market Signals| Indicator | LE | LXRX |
|---|---|---|
| Relative Strength Index (RSI) | 48.86 | 43.02 |
| Support Level | $13.50 | $1.29 |
| Resistance Level | $17.12 | $1.48 |
| Average True Range (ATR) | 0.99 | 0.07 |
| MACD | -0.09 | -0.01 |
| Stochastic Oscillator | 53.59 | 10.53 |
Price Performance
Historical ComparisonAbout LE Lands' End Inc.
Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically operates in USA, Europe, Asia, it derives a majority of its revenue from the United States.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.